New research shows COVID-19 raises the risk of Guillain-Barré syndrome more than vaccines. mRNA vaccines pose no increased risk, global data reveals.

A judge dismissed an attempt to use a bankruptcy court to resolve tens of thousands of claims that the company’s talcum power products caused cancer.

The United States Food and Drug Administration (FDA) has warned that the COVID-19 vaccine developed by Johnson & Johnson may be linked to a small increased risk of Guillain-Barré syndrome, a ...

A new study has found no evidence that COVID-19 shots increase the incidence of Guillain-Barré syndrome, according to researchers.

New surveillance data from the Vaccine Safety Datalink confirm a small but statistically significant increased risk for Guillain-Barré syndrome (GBS) in the 3 weeks after receipt of the Janssen ...

The risk for developing Guillain-Barré syndrome, a condition that causes severe muscle weakness, after receipt of a COVID-19 vaccine is small, but higher with the Johnson & Johnson shot ...

The Food and Drug Administration (FDA) has judged that the Johnson & Johnson vaccine confers an increased risk of Guillain-Barre syndrome – a controversial decision given the high population of ...

Guillain-Barre Syndrome (GBS) has been reported among the more severe side effects. Study: Guillain-Barré Syndrome following SARS-CoV-2 vaccination: is there a real association?

Two months after the FDA flagged Johnson & Johnson’s COVID-19 vaccine for the rare nerve disorder Guillain-Barre syndrome (GBS) Europe’s drug regulator has done the same for AstraZeneca’s ...

Preliminary reports show that 100 cases of Guillain-Barre syndrome following use of the J&J vaccine were reported out of more than 12 million doses administered.